Zobrazeno 1 - 10
of 1 668
pro vyhledávání: '"olaparib (Lynparza™)"'
Publikováno v:
The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2023 Jun 26; Vol. 65 (1679), pp. e106-e107. Date of Electronic Publication: 2023 Jun 26.
Autor:
null CADTH
Publikováno v:
Canadian Journal of Health Technologies. 3
CADTH reimbursement reviews are comprehensive assessments of the clinical effectiveness and cost-effectiveness, as well as patient and clinician perspectives, of a drug or drug class. The assessments inform non-binding recommendations that help guide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c721022e56e6d93069765a117961d86
https://doi.org/10.51731/cjht.2023.602
https://doi.org/10.51731/cjht.2023.602
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2016 Feb 29; Vol. 58 (1489), pp. e32-3. Date of Electronic Publication: 2016 Feb 29.
Autor:
Inoue, Takahiro1 (AUTHOR) momosekisho@gmail.com, Sekito, Sho1 (AUTHOR), Kageyama, Takumi1 (AUTHOR), Sugino, Yusuke1 (AUTHOR), Sasaki, Takeshi1 (AUTHOR)
Publikováno v:
Cancers. May2023, Vol. 15 Issue 9, p2662. 13p.
Autor:
Kendall C. Shultes
Publikováno v:
Oncology Times. 40:21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a36868ea16474b24e5ae5bd579498453
https://doi.org/10.1097/01.cot.0000550785.92046.7c
https://doi.org/10.1097/01.cot.0000550785.92046.7c
Autor:
Tomasz Sliwinski, Reinhard Dummer, Mitchell P. Levesque, Daniel Gritsyuk, Grazyna Hoser, Malgorzata Czyz, Janusz Szemraj, Tomasz Skorski, Phil F. Cheng, Monika Toma, Margaret Nieborowska-Skorska, Kinga Majchrzak, Anna Gajos-Michniewicz
Publikováno v:
Oncotarget
Cancer including melanoma may be ''addicted" to double strand break (DSB) repair and targeting this process could sensitize them to the lethal effect of DNA damage. PARP1 exerts an important impact on DSB repair as it binds to both single- and double
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e2199c5c64615bbf751e8987c9d24d9
Autor:
Ryota Tashiro, Hitoshi Kawazoe, Kanako Mamishin, Keisuke Seto, Ryoko Udagawa, Yoshimasa Saito, Hironobu Hashimoto, Tatsunori Shimoi, Kan Yonemori, Masahito Yonemura, Hiroyuki Terakado, Toshikatsu Kawasaki, Tetsuya Furukawa, Tomonori Nakamura
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundOlaparib-induced anemia is a frequently occurring complication in patients with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer and is associated with a marked deterioration in patients’ health-related quality
Externí odkaz:
https://doaj.org/article/4a7f9c552d79479c93a8989899915f64
Autor:
Francesco Schettini, Silvia Paola Corona, Fabiola Giudici, Carla Strina, Marianna Sirico, Ottavia Bernocchi, Manuela Milani, Nicoletta Ziglioli, Sergio Aguggini, Carlo Azzini, Giuseppina Barbieri, Valeria Cervoni, Maria Rosa Cappelletti, Alfredo Molteni, Maria Chiara Lazzari, Giuseppina Ferrero, Marco Ungari, Elena Marasco, Alice Bruson, Luciano Xumerle, Elisa Zago, Davide Cerra, Marco Loddo, Gareth H. Williams, Ida Paris, Giovanni Scambia, Daniele Generali
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
IntroductionOlaparib is effective in metastatic triple negative breast cancer (TNBC) carrying germline mutations in DNA damage repair (DDR) genes BRCA1/2 (gBRCA-mut). The OLTRE window-of-opportunity trial preliminarily investigated potential patholog
Externí odkaz:
https://doaj.org/article/63788280c6b64a3b8d56a89d2a4c7a48